Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis

scientific article published on 30 September 2009

Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JNCI/DJP320
P698PubMed publication ID19794130

P2093author name stringJayesh Mehta
P2860cites workFirst-line thalidomide-dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myelomaQ46558044
Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trialQ46745193
P433issue20
P304page(s)1430-1; author reply 1431-3
P577publication date2009-09-30
P1433published inJournal of the National Cancer InstituteQ400279
P1476titleRe: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis
P478volume101

Reverse relations

cites work (P2860)
Q24197999First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
Q35802414International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation